about
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Read More
1,791
XNAS Volume
High volume today
XNAS 16 May, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Trevena Inc is on 27 May 2025 for the purpose of Trevena Inc Annual Report for 2024
See details
Not Eligible
Expensive Valuation
Technically Bearish
Trevena Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..